SCHEMBL6296173

SCHEMBL6296173

[CH2]c1ccc(-c2ccc(F)c(F)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
NOTUM Q6P988 1/20 0.41
HSD17B1 P14061 3/20 0.36
HSD17B2 P37059 3/20 0.36
KIF11 P52732 3/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PGR P06401 3/20 0.35
PDGFRB P09619 1/20 0.35
PDGFRA P16234 1/20 0.35
CES2 O00748 1/20 0.34
CES1 P23141 1/20 0.34
KMO O15229 1/20 0.34
TRPA1 O75762 1/20 0.34
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13741967 0.84 CYP17A1 (0.52) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL2090822 0.79 DAPK3 (0.44) HSD17B1HSD17B2
SCHEMBL2093613 0.79 HSD17B1 (0.44) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL19665044 0.79 CYP11B1 (0.50) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL56600 0.78
SCHEMBL2552043 0.77 CYP11B1 (0.48) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL7769653 0.77 ALOX5 (0.50) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL7766400 0.77 CYP11B2 (0.48) CYP17A1CYP11B1CYP11B2NOTUMHSD17B1
SCHEMBL28041388 0.76 CES2 (0.39) NOTUMCES2CES1
SCHEMBL265481 0.75 NFE2L2 (0.54) CYP17A1CYP11B1CYP11B2NOTUMPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1705670-A 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds OTSUKA PHARMA CO LTD (JP) 2005-12-07 CN disclosed
US-6927216-B2 Cyclic sulfonyl compounds as inhibitors of metalloproteases BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-08-09 US disclosed